Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 11/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CA6 | P23280 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.50 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29578190 | 1.00 | PTGES2 (0.64) | PTGES2LMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL10593744 | 0.88 | CA2 (0.52) | PTGES2LMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL11647231 | 0.82 | CA1 (0.52) | PTGES2LMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL121865 | 0.81 | CA2 (0.56) | PTGES2LMNAALDH1A1TSHRCA1 | |
| SCHEMBL29356372 | 0.81 | CA2 (0.56) | PTGES2LMNAALDH1A1TSHRCA1 | |
| SCHEMBL1248188 | 0.81 | AKR1B1 (0.56) | PTGES2LMNAMEN1ALDH1A1KMT2A | |
| SCHEMBL25301662 | 0.80 | CA2 (0.45) | PTGES2LMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL3531209 | 0.80 | CA2 (0.61) | PTGES2LMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL28335651 | 0.80 | CA2 (0.61) | PTGES2LMNAKDM4EMEN1ALDH1A1 | |
| SCHEMBL3775622 | 0.79 | PTGES2 (1.00) | PTGES2CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113966397-A | Human carbonic anhydrase 2 compositions and methods for tunable modulation | 黑曜石疗法公司 | 2022-01-21 | — | — | CN | claimed |
| WO-2019048988-A1 | NOVEL FUNGIDAL HETEROCYCLIC COMPOUNDS | PI INDUSTRIES LTD. (IN) | 2019-03-14 | — | — | WO | claimed |
| EP-3186333-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | Cao, Zhengbing (US) | 2017-07-05 | — | — | EP | claimed |
| WO-2016033340-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | CAO ZHENGBING (US) | 2016-03-03 | — | — | WO | claimed |
| WO-2007035154-A1 | NOVEL N-PYRAZINIL-PHENYLSULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF ASTHMA | ASTRAZENECA AB (SE) | 2007-03-29 | — | — | WO | claimed |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | ILLIG CARL R (US) | 2001-10-18 | — | — | US | claimed |
| EP-0315204-A2 | Bleaching composition | LION CORPORATION (JP) | 1989-05-10 | — | — | EP | claimed |
| JP-61254631-A | — | — | None | — | — | JP | disclosed |
| JP-61254630-A | — | — | None | — | — | JP | disclosed |
| US-20260103758-A1 | METHODS AND BIOMARKERS FOR TREATING BREAST CANCER | KING ABDULAZIZ UNIVERSITY (SA) | 2026-04-16 | — | — | US | disclosed |
| EP-3364976-B1 | PIPERAZINYL NORBENZOMORPHAN COMPOUNDS AND METHODS FOR USING THE SAME | UNIV TEXAS (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12527763-B2 | Pyrrole amide compound and use thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2026-01-20 | — | — | US | disclosed |
| US-20250320184-A1 | SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF | SIRONAX LTD (KY) | 2025-10-16 | — | — | US | disclosed |
| WO-1995022785-A1 | PHOTOTHERMOGRAPHIC ELEMENT WITH CORE-SHELL-TYPE SILVER HALIDE GRAINS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-08-24 | — | — | WO | disclosed |
| EP-0328291-A1 | Halogenated polybutadiene series elastomers, method of producing the same, and rubber compositions for tires containing the elastomer | Bridgestone Corporation (JP) | 1989-08-16 | — | — | EP | disclosed |
| US-4645527-A | PLANT SAFENING AGENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-02-24 | — | — | US | disclosed |
| JP-S61254631-A | BONDING OF PHOTO-SENSITIVE FLEXOGRAPHIC PRINTING PLATE AND RUBBER BACKING MATERIAL | NIPPON ZEON CO LTD | 1986-11-12 | — | — | JP | disclosed |
| JP-S61254630-A | METHOD FOR BONDING RUBBERY SHEET AND POLYESTER SHEET | NIPPON ZEON CO LTD | 1986-11-12 | — | — | JP | disclosed |
| EP-0060120-B1 | PROCESS FOR PREPARING 4-HALOAZETIDIN-2-ONES | ELI LILLY AND COMPANY (US) | 1984-12-19 | — | — | EP | disclosed |
| EP-0033984-B1 | NEW SULPHONYL COMPOUNDS, METHOD OF PREPARING THE NEW COMPOUNDS, AS WELL AS APHICIDAL COMPOSITIONS ON THE BASIS OF THE NEW COMPOUNDS | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1984-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320184-A1 | SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF | SARM1, SMN1; SMN2, ADRM1 | PTGES2 3788/4885LMNA 907/4885KDM4E 3435/4885 |
| US-20260103758-A1 | METHODS AND BIOMARKERS FOR TREATING BREAST CANCER | THRAP3, ACTR2, ACTR3 | PTGES2 3755/4885LMNA 4298/4885KDM4E 4488/4885 |
| US-12527763-B2 | Pyrrole amide compound and use thereof | NR3C2, AVPR2, MC2R | PTGES2 354/4885LMNA 3885/4885KDM4E 1437/4885 |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | SERPINE1, PRSS3, PRSS2 | PTGES2 3057/4885LMNA 850/4885KDM4E 3095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.